Amusing to see Roche management buy all these small companies with little to no forethought.
The sequencing business definitely seems like a very long shot in the dark. These idiots couldn't leverage a well-established technology like 454, but are on a wild goose chase with the Genia nanopore technology, that nobody here seems to have a clue about.
I think I have a fairly good idea who is in line to be affected next. Your guesses?
The sequencing business definitely seems like a very long shot in the dark. These idiots couldn't leverage a well-established technology like 454, but are on a wild goose chase with the Genia nanopore technology, that nobody here seems to have a clue about.
I think I have a fairly good idea who is in line to be affected next. Your guesses?
Next round of layoffs at Roche.
Aucun commentaire:
Enregistrer un commentaire